InsiderDB

Lobbying disclosures · Lobbying report

BMRN: third_quarter 2026 lobbying report

Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.

Follow BMRN
Became public
Oct 20, 2026, 1:22 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 4:07 PM EST

Why this is connected

Exact legal-name match: BIOMARIN PHARMACEUTICAL INC (https://www.sec.gov/Archives/edgar/data/1048477/).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/e1949287-4649-4faa-b202-f81a6eb76aab/","filing_uuid":"e1949287-4649-4faa-b202-f81a6eb76aab","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e1949287-4649-4faa-b202-f81a6eb76aab/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chelsea J. Mincheff","dt_posted":"2026-10-20T13:22:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-07-30T12:12:37.308899-04:00"},"client":{"id":55421,"url":"https://lda.gov/api/v1/clients/55421/","client_id":55421,"name":"BIOMARIN PHARMACEUTICAL INC.","general_description":"Biotechnology company","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-03-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62729,"prefix":null,"prefix_display":null,"first_name":"BRENT","nickname":null,"middle_name":"ALAN","last_name":"DEL MONTE","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee","new":false},{"lobbyist":{"id":143823,"prefix":"ms","prefix_display":"MS.","first_name":"REMY","nickname":null,"middle_name":"LEIGH BRIM","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":"Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz","new":false},{"lobbyist":{"id":73551,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"FARMER","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space","new":false},{"lobbyist":{"id":67545,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":"Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C","new":false},{"lobbyist":{"id":121840,"prefix":null,"prefix_display":null,"first_name":"JOEL","nickname":null,"middle_name":"D.","last_name":"BAILEY","suffix":null,"suffix_display":null},"covered_position":"COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in BMRN

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.